奥曲肽和血必净注射液联合应用在急性胰腺炎临床疗效的研究  

To observe the clinical effect of octreotide combined with Xuebijing injection in the treatment of acute pancreatitis

作　　者：张勇[1] 鲁加煜 康欣[1] 

机构地区：[1]四川省成都市双流县第一人民医院普外科,610200

出　　处：《检验医学与临床》2016年第9期1224-1225,共2页Laboratory Medicine and Clinic

摘　　要：目的奥曲肽和血必净注射液联合应用在急性胰腺炎的临床疗效观察。方法收集该院83例急性胰腺炎患者,采用对照方法,将患者分为治疗组和对照组,治疗组联合应用奥曲肽和血必净注射液,对照组单用奥曲肽。监测患者临床症状和各实验室指标的改善情况。结果治疗组和对照组的治疗有效率差异有统计学意义(P<0.05),治疗组的各临床症状改善时间总体优于对照组。经治疗后,2组的炎性指标以及血、尿淀粉酶水平差异有统计学意义(P<0.05)。结论联合应用奥曲肽和血必净注射液可显著提高急性胰腺炎患者的疗效。Objective To investigate the clinical efficacy of combination of Octreotide and Xuebijing injection in the treatment of acute pancreatitis .Methods Eighty‐three cases of patients with acute pancreatitis were randomly divided into control and treatment groups .These groups were treated with Octreotide and combination of Octreotide and Xuebijing injection respectively .Clinical symptoms and laboratory parameters were observed .Results The clini‐cal efficacy of the two groups were significantly different .The attenuation of clinical symptoms in treatment groups were better than that in control group .After treatment ,the laboratory parameters in the two groups were significant‐ly different .Conclusion Take the combination of Octreotide and Xuebijing injection to cure acute pancreatitis had a better clinical efficacy .

关 键 词：奥曲肽 血必净注射液 急性胰腺炎 尿淀粉酶 

分 类 号：R259.9[医药卫生—中西医结合]